Skip to main content
Top
Published in: Molecular Cancer 1/2011

Open Access 01-12-2011 | Research

Short-chain fatty acid level and field cancerization show opposing associations with enteroendocrine cell number and neuropilin expression in patients with colorectal adenoma

Authors: Danny CW Yu, Jonathan P Bury, James Tiernan, Jennifer S Waby, Carolyn A Staton, Bernard M Corfe

Published in: Molecular Cancer | Issue 1/2011

Login to get access

Abstract

Background

Previous reports have suggested that the VEGF receptor neuropilin-1 (NRP-1) is expressed in a singly dispersed subpopulation of cells in the normal colonic epithelium, but that expression becomes dysregulated during colorectal carcinogenesis, with higher levels in tumour suggestive of a poor prognosis. We noted that the spatial distribution and morphology if NRP-1 expressing cells resembles that of enteroendocrine cells (EEC) which are altered in response to disease state including cancer and irritable bowel syndrome (IBS). We have shown that NRP-1 is down-regulated by butyrate in colon cancer cell lines in vitro and we hypothesized that butyrate produced in the lumen would have an analogous effect on the colon mucosa in vivo. Therefore we sought to investigate whether NRP-1 is expressed in EEC and how NRP-1 and EEC respond to butyrate and other short-chain fatty acids (SCFA - principally acetate and propionate). Additionally we sought to assess whether there is a field effect around adenomas.

Methodology

Biopsies were collected at the mid-sigmoid, at the adenoma and at the contralateral wall (field) of 28 subjects during endoscopy. Samples were fixed for IHC and stained for either NRP-1 or for chromogranin A (CgA), a marker of EEC. Stool sampling was undertaken to assess individuals' butyrate, acetate and propionate levels.

Result

NRP-1 expression was inversely related to SCFA concentration at the colon landmark (mid-sigmoid), but expression was lower and not related to SCFA concentration at the field. Likewise CgA+ cell number was also inversely related to SCFA at the landmark, but was lower and unresponsive at the field. Crypt cellularity was unaltered by field effect. A colocalisation analysis showed only a small subset of NRP-1 localised with CgA. Adenomas showed extensive, weaker staining for NRP-1 which contrastingly correlated positively with butyrate level. Field effects cause this relationship to be lost. Adenoma tissue shows dissociation of the co-regulation of NRP-1 and EEC.

Conclusion

NRP-1 is inversely associated with levels of butyrate and other SCFA in vivo and is expressed in a subset of CgA expressing cells. EEC number is related to butyrate level in the same way.
Appendix
Available only for authorised users
Literature
1.
go back to reference Bingham SA, Day NE, Luben R, Ferrari P, Slimani N, Norat T, Clavel-Chapelon F, Kesse E, Nieters A, Boeing H: Dietary fibre in food and protection against colorectal cancer in the European Prospective Investigation into Cancer and Nutrition (EPIC): an observational study. Lancet. 2003, 361: 1496-1501. 10.1016/S0140-6736(03)13174-1CrossRefPubMed Bingham SA, Day NE, Luben R, Ferrari P, Slimani N, Norat T, Clavel-Chapelon F, Kesse E, Nieters A, Boeing H: Dietary fibre in food and protection against colorectal cancer in the European Prospective Investigation into Cancer and Nutrition (EPIC): an observational study. Lancet. 2003, 361: 1496-1501. 10.1016/S0140-6736(03)13174-1CrossRefPubMed
2.
go back to reference Peters U, Sinha R, Chatterjee N, Subar AF, Ziegler RG, Kulldorff M, Bresalier R, Weissfeld JL, Flood A, Schatzkin A, Hayes RB: Dietary fibre and colorectal adenoma in a colorectal cancer early detection programme. Lancet. 2003, 361: 1491-1495. 10.1016/S0140-6736(03)13173-XCrossRefPubMed Peters U, Sinha R, Chatterjee N, Subar AF, Ziegler RG, Kulldorff M, Bresalier R, Weissfeld JL, Flood A, Schatzkin A, Hayes RB: Dietary fibre and colorectal adenoma in a colorectal cancer early detection programme. Lancet. 2003, 361: 1491-1495. 10.1016/S0140-6736(03)13173-XCrossRefPubMed
3.
go back to reference McIntyre A, Gibson PR, Young GP: Butyrate production from dietary fibre and protection against large bowel cancer in a rat model. Gut. 1993, 34: 386-391. 10.1136/gut.34.3.386PubMedCentralCrossRefPubMed McIntyre A, Gibson PR, Young GP: Butyrate production from dietary fibre and protection against large bowel cancer in a rat model. Gut. 1993, 34: 386-391. 10.1136/gut.34.3.386PubMedCentralCrossRefPubMed
4.
go back to reference Pili R, Kruszewski MP, Hager BW, Lantz J, Carducci MA: Combination of phenylbutyrate and 13-cis retinoic acid inhibits prostate tumor growth and angiogenesis. Cancer Res. 2001, 61: 1477-1485.PubMed Pili R, Kruszewski MP, Hager BW, Lantz J, Carducci MA: Combination of phenylbutyrate and 13-cis retinoic acid inhibits prostate tumor growth and angiogenesis. Cancer Res. 2001, 61: 1477-1485.PubMed
5.
go back to reference Medina V, Edmonds B, Young GP, James R, Appleton S, Zalewski PD: Induction of caspase-3 protease activity and apoptosis by butyrate and trichostatin A (inhibitors of histone deacetylase): dependence on protein synthesis and synergy with a mitochondrial/cytochrome c-dependent pathway. Cancer Res. 1997, 57: 3697-3707.PubMed Medina V, Edmonds B, Young GP, James R, Appleton S, Zalewski PD: Induction of caspase-3 protease activity and apoptosis by butyrate and trichostatin A (inhibitors of histone deacetylase): dependence on protein synthesis and synergy with a mitochondrial/cytochrome c-dependent pathway. Cancer Res. 1997, 57: 3697-3707.PubMed
6.
go back to reference Schwartz B, Avivi-Green C, Polak-Charcon S: Sodium butyrate induces retinoblastoma protein dephosphorylation, p16 expression and growth arrest of colon cancer cells. Mol Cell Biochem. 1998, 188: 21-30. 10.1023/A:1006831330340CrossRefPubMed Schwartz B, Avivi-Green C, Polak-Charcon S: Sodium butyrate induces retinoblastoma protein dephosphorylation, p16 expression and growth arrest of colon cancer cells. Mol Cell Biochem. 1998, 188: 21-30. 10.1023/A:1006831330340CrossRefPubMed
7.
go back to reference Yu DC, Waby JS, Chirakkal H, Staton CA, Corfe BM: Butyrate suppresses expression of neuropilin I in colorectal cell lines through inhibition of Sp1 transactivation. Mol Cancer. 2010, 9: 276- 10.1186/1476-4598-9-276PubMedCentralCrossRefPubMed Yu DC, Waby JS, Chirakkal H, Staton CA, Corfe BM: Butyrate suppresses expression of neuropilin I in colorectal cell lines through inhibition of Sp1 transactivation. Mol Cancer. 2010, 9: 276- 10.1186/1476-4598-9-276PubMedCentralCrossRefPubMed
8.
go back to reference He Z, Tessier-Lavigne M: Neuropilin is a receptor for the axonal chemorepellent Semaphorin III. Cell. 1997, 90: 739-751. 10.1016/S0092-8674(00)80534-6CrossRefPubMed He Z, Tessier-Lavigne M: Neuropilin is a receptor for the axonal chemorepellent Semaphorin III. Cell. 1997, 90: 739-751. 10.1016/S0092-8674(00)80534-6CrossRefPubMed
9.
go back to reference Kowanetz M, Ferrara N: Vascular endothelial growth factor signaling pathways: therapeutic perspective. Clin Cancer Res. 2006, 12: 5018-5022. 10.1158/1078-0432.CCR-06-1520CrossRefPubMed Kowanetz M, Ferrara N: Vascular endothelial growth factor signaling pathways: therapeutic perspective. Clin Cancer Res. 2006, 12: 5018-5022. 10.1158/1078-0432.CCR-06-1520CrossRefPubMed
10.
go back to reference Staton CA, Kumar I, Reed MW, Brown NJ: Neuropilins in physiological and pathological angiogenesis. J Pathol. 2007, 212: 237-248. 10.1002/path.2182CrossRefPubMed Staton CA, Kumar I, Reed MW, Brown NJ: Neuropilins in physiological and pathological angiogenesis. J Pathol. 2007, 212: 237-248. 10.1002/path.2182CrossRefPubMed
11.
go back to reference Staton CA, Chetwood AS, Cameron IC, Cross SS, Brown NJ, Reed MW: The angiogenic switch occurs at the adenoma stage of the adenoma carcinoma sequence in colorectal cancer. Gut. 2007, 56: 1426-1432. 10.1136/gut.2007.125286PubMedCentralCrossRefPubMed Staton CA, Chetwood AS, Cameron IC, Cross SS, Brown NJ, Reed MW: The angiogenic switch occurs at the adenoma stage of the adenoma carcinoma sequence in colorectal cancer. Gut. 2007, 56: 1426-1432. 10.1136/gut.2007.125286PubMedCentralCrossRefPubMed
12.
go back to reference Parikh AA, Fan F, Liu WB, Ahmad SA, Stoeltzing O, Reinmuth N, Bielenberg D, Bucana CD, Klagsbrun M, Ellis LM: Neuropilin-1 in human colon cancer: expression, regulation, and role in induction of angiogenesis. Am J Pathol. 2004, 164: 2139-2151. 10.1016/S0002-9440(10)63772-8PubMedCentralCrossRefPubMed Parikh AA, Fan F, Liu WB, Ahmad SA, Stoeltzing O, Reinmuth N, Bielenberg D, Bucana CD, Klagsbrun M, Ellis LM: Neuropilin-1 in human colon cancer: expression, regulation, and role in induction of angiogenesis. Am J Pathol. 2004, 164: 2139-2151. 10.1016/S0002-9440(10)63772-8PubMedCentralCrossRefPubMed
13.
go back to reference Hansel DE, Wilentz RE, Yeo CJ, Schulick RD, Montgomery E, Maitra A: Expression of neuropilin-1 in high-grade dysplasia, invasive cancer, and metastases of the human gastrointestinal tract. Am J Surg Pathol. 2004, 28: 347-356. 10.1097/00000478-200403000-00007CrossRefPubMed Hansel DE, Wilentz RE, Yeo CJ, Schulick RD, Montgomery E, Maitra A: Expression of neuropilin-1 in high-grade dysplasia, invasive cancer, and metastases of the human gastrointestinal tract. Am J Surg Pathol. 2004, 28: 347-356. 10.1097/00000478-200403000-00007CrossRefPubMed
14.
go back to reference Ochiumi T, Kitadai Y, Tanaka S, Akagi M, Yoshihara M, Chayama K: Neuropilin-1 is involved in regulation of apoptosis and migration of human colon cancer. Int J Oncol. 2006, 29: 105-116.PubMed Ochiumi T, Kitadai Y, Tanaka S, Akagi M, Yoshihara M, Chayama K: Neuropilin-1 is involved in regulation of apoptosis and migration of human colon cancer. Int J Oncol. 2006, 29: 105-116.PubMed
15.
go back to reference Aiken KD, Kisslinger JA, Roth KA: Immunohistochemical studies indicate multiple enteroendocrine cell differentiation pathways in the mouse proximal small intestine. Dev Dyn. 1994, 201: 63-70. 10.1002/aja.1002010107CrossRefPubMed Aiken KD, Kisslinger JA, Roth KA: Immunohistochemical studies indicate multiple enteroendocrine cell differentiation pathways in the mouse proximal small intestine. Dev Dyn. 1994, 201: 63-70. 10.1002/aja.1002010107CrossRefPubMed
16.
go back to reference Dunlop SP, Jenkins D, Neal KR, Spiller RC: Relative importance of enterochromaffin cell hyperplasia, anxiety, and depression in postinfectious IBS. Gastroenterology. 2003, 125: 1651-1659. 10.1053/j.gastro.2003.09.028CrossRefPubMed Dunlop SP, Jenkins D, Neal KR, Spiller RC: Relative importance of enterochromaffin cell hyperplasia, anxiety, and depression in postinfectious IBS. Gastroenterology. 2003, 125: 1651-1659. 10.1053/j.gastro.2003.09.028CrossRefPubMed
17.
go back to reference Nitta Y, Nishibori M, Iwagaki H, Yoshino T, Mori S, Sawada K, Nakaya N, Saeki K, Tanaka N: Changes in serotonin dynamics in the gastrointestinal tract of colon-26 tumour-bearing mice: effects of cisplatin treatment. Naunyn Schmiedebergs Arch Pharmacol. 2001, 364: 329-334. 10.1007/s002100100461CrossRefPubMed Nitta Y, Nishibori M, Iwagaki H, Yoshino T, Mori S, Sawada K, Nakaya N, Saeki K, Tanaka N: Changes in serotonin dynamics in the gastrointestinal tract of colon-26 tumour-bearing mice: effects of cisplatin treatment. Naunyn Schmiedebergs Arch Pharmacol. 2001, 364: 329-334. 10.1007/s002100100461CrossRefPubMed
18.
go back to reference Gulubova M, Vlaykova T: Chromogranin A-, serotonin-, synaptophysin- and vascular endothelial growth factor-positive endocrine cells and the prognosis of colorectal cancer: an immunohistochemical and ultrastructural study. J Gastroenterol Hepatol. 2008, 23: 1574-1585. 10.1111/j.1440-1746.2008.05560.xCrossRefPubMed Gulubova M, Vlaykova T: Chromogranin A-, serotonin-, synaptophysin- and vascular endothelial growth factor-positive endocrine cells and the prognosis of colorectal cancer: an immunohistochemical and ultrastructural study. J Gastroenterol Hepatol. 2008, 23: 1574-1585. 10.1111/j.1440-1746.2008.05560.xCrossRefPubMed
19.
go back to reference Tazoe H, Otomo Y, Karaki S, Kato I, Fukami Y, Terasaki M, Kuwahara A: Expression of short-chain fatty acid receptor GPR41 in the human colon. Biomed Res. 2009, 30: 149-156. 10.2220/biomedres.30.149CrossRefPubMed Tazoe H, Otomo Y, Karaki S, Kato I, Fukami Y, Terasaki M, Kuwahara A: Expression of short-chain fatty acid receptor GPR41 in the human colon. Biomed Res. 2009, 30: 149-156. 10.2220/biomedres.30.149CrossRefPubMed
20.
go back to reference Portela-Gomes GM, Stridsberg M, Johansson H, Grimelius L: Complex co-localization of chromogranins and neurohormones in the human gastrointestinal tract. J Histochem Cytochem. 1997, 45: 815-822.CrossRefPubMed Portela-Gomes GM, Stridsberg M, Johansson H, Grimelius L: Complex co-localization of chromogranins and neurohormones in the human gastrointestinal tract. J Histochem Cytochem. 1997, 45: 815-822.CrossRefPubMed
21.
go back to reference Karaki S, Tazoe H, Hayashi H, Kashiwabara H, Tooyama K, Suzuki Y, Kuwahara A: Expression of the short-chain fatty acid receptor, GPR43, in the human colon. J Mol Histol. 2008, 39: 135-142. 10.1007/s10735-007-9145-yCrossRefPubMed Karaki S, Tazoe H, Hayashi H, Kashiwabara H, Tooyama K, Suzuki Y, Kuwahara A: Expression of the short-chain fatty acid receptor, GPR43, in the human colon. J Mol Histol. 2008, 39: 135-142. 10.1007/s10735-007-9145-yCrossRefPubMed
22.
go back to reference Kim BJ, Park KH, Yim CY, Takasawa S, Okamoto H, Im MJ, Kim UH: Generation of nicotinic acid adenine dinucleotide phosphate and cyclic ADP-ribose by glucagon-like peptide-1 evokes Ca2+ signal that is essential for insulin secretion in mouse pancreatic islets. Diabetes. 2008, 57: 868-878. 10.2337/db07-0443CrossRefPubMed Kim BJ, Park KH, Yim CY, Takasawa S, Okamoto H, Im MJ, Kim UH: Generation of nicotinic acid adenine dinucleotide phosphate and cyclic ADP-ribose by glucagon-like peptide-1 evokes Ca2+ signal that is essential for insulin secretion in mouse pancreatic islets. Diabetes. 2008, 57: 868-878. 10.2337/db07-0443CrossRefPubMed
23.
go back to reference Cani PD, Hoste S, Guiot Y, Delzenne NM: Dietary non-digestible carbohydrates promote L-cell differentiation in the proximal colon of rats. Br J Nutr. 2007, 98: 32-37. 10.1017/S0007114507691648CrossRefPubMed Cani PD, Hoste S, Guiot Y, Delzenne NM: Dietary non-digestible carbohydrates promote L-cell differentiation in the proximal colon of rats. Br J Nutr. 2007, 98: 32-37. 10.1017/S0007114507691648CrossRefPubMed
24.
go back to reference Cho KH, Lee HS, Ku SK: Decrease in intestinal endocrine cells in Balb/c mice with CT-26 carcinoma cells. J Vet Sci. 2008, 9: 9-14. 10.4142/jvs.2008.9.1.9PubMedCentralCrossRefPubMed Cho KH, Lee HS, Ku SK: Decrease in intestinal endocrine cells in Balb/c mice with CT-26 carcinoma cells. J Vet Sci. 2008, 9: 9-14. 10.4142/jvs.2008.9.1.9PubMedCentralCrossRefPubMed
25.
go back to reference Hanahan D, Weinberg RA: The hallmarks of cancer. Cell. 2000, 100: 57-70. 10.1016/S0092-8674(00)81683-9CrossRefPubMed Hanahan D, Weinberg RA: The hallmarks of cancer. Cell. 2000, 100: 57-70. 10.1016/S0092-8674(00)81683-9CrossRefPubMed
26.
go back to reference Roediger WE: Utilization of nutrients by isolated epithelial cells of the rat colon. Gastroenterology. 1982, 83: 424-429.PubMed Roediger WE: Utilization of nutrients by isolated epithelial cells of the rat colon. Gastroenterology. 1982, 83: 424-429.PubMed
27.
go back to reference Velazquez OC, Lederer HM, Rombeau JL: Butyrate and the colonocyte. Implications for neoplasia. Dig Dis Sci. 1996, 41: 727-739. 10.1007/BF02213129CrossRefPubMed Velazquez OC, Lederer HM, Rombeau JL: Butyrate and the colonocyte. Implications for neoplasia. Dig Dis Sci. 1996, 41: 727-739. 10.1007/BF02213129CrossRefPubMed
28.
go back to reference Lupton JR: Microbial degradation products influence colon cancer risk: the butyrate controversy. J Nutr. 2004, 134: 479-482.PubMed Lupton JR: Microbial degradation products influence colon cancer risk: the butyrate controversy. J Nutr. 2004, 134: 479-482.PubMed
29.
go back to reference Lupton JR: Is fiber protective against colon cancer? Where the research is leading us. Nutrition. 2000, 16: 558-561. 10.1016/S0899-9007(00)00350-6CrossRefPubMed Lupton JR: Is fiber protective against colon cancer? Where the research is leading us. Nutrition. 2000, 16: 558-561. 10.1016/S0899-9007(00)00350-6CrossRefPubMed
30.
go back to reference Chirakkal H, Leech SH, Brookes KE, Prais AL, Waby JS, Corfe BM: Upregulation of BAK by butyrate in the colon is associated with increased Sp3 binding. Oncogene. 2006, 25: 7192-7200. 10.1038/sj.onc.1209702CrossRefPubMed Chirakkal H, Leech SH, Brookes KE, Prais AL, Waby JS, Corfe BM: Upregulation of BAK by butyrate in the colon is associated with increased Sp3 binding. Oncogene. 2006, 25: 7192-7200. 10.1038/sj.onc.1209702CrossRefPubMed
31.
go back to reference Kim YI: Will mandatory folic acid fortification prevent or promote cancer?. Am J Clin Nutr. 2004, 80: 1123-1128.PubMed Kim YI: Will mandatory folic acid fortification prevent or promote cancer?. Am J Clin Nutr. 2004, 80: 1123-1128.PubMed
32.
go back to reference Giovannucci E: Epidemiologic studies of folate and colorectal neoplasia: a review. J Nutr. 2002, 132: 2350S-2355S.PubMed Giovannucci E: Epidemiologic studies of folate and colorectal neoplasia: a review. J Nutr. 2002, 132: 2350S-2355S.PubMed
33.
go back to reference Cole JW, Holden WD: Postcolectomy regression of adenomatous polyps of the rectum. Arch Surg. 1959, 79: 385-392.CrossRefPubMed Cole JW, Holden WD: Postcolectomy regression of adenomatous polyps of the rectum. Arch Surg. 1959, 79: 385-392.CrossRefPubMed
34.
go back to reference Macfarlane S, Macfarlane GT: Regulation of short-chain fatty acid production. Proc Nutr Soc. 2003, 62: 67-72. 10.1079/PNS2002207CrossRefPubMed Macfarlane S, Macfarlane GT: Regulation of short-chain fatty acid production. Proc Nutr Soc. 2003, 62: 67-72. 10.1079/PNS2002207CrossRefPubMed
35.
go back to reference Slaughter DP, Southwick HW, Smejkal W: Field cancerization in oral stratified squamous epithelium; clinical implications of multicentric origin. Cancer. 1953, 6: 963-968. 10.1002/1097-0142(195309)6:5<963::AID-CNCR2820060515>3.0.CO;2-QCrossRefPubMed Slaughter DP, Southwick HW, Smejkal W: Field cancerization in oral stratified squamous epithelium; clinical implications of multicentric origin. Cancer. 1953, 6: 963-968. 10.1002/1097-0142(195309)6:5<963::AID-CNCR2820060515>3.0.CO;2-QCrossRefPubMed
36.
go back to reference Humphries A, Wright NA: Colonic crypt organization and tumorigenesis. Nat Rev Cancer. 2008, 8: 415-424. 10.1038/nrc2392CrossRefPubMed Humphries A, Wright NA: Colonic crypt organization and tumorigenesis. Nat Rev Cancer. 2008, 8: 415-424. 10.1038/nrc2392CrossRefPubMed
37.
go back to reference Braakhuis BJ, Tabor MP, Kummer JA, Leemans CR, Brakenhoff RH: A genetic explanation of Slaughter's concept of field cancerization: evidence and clinical implications. Cancer Res. 2003, 63: 1727-1730.PubMed Braakhuis BJ, Tabor MP, Kummer JA, Leemans CR, Brakenhoff RH: A genetic explanation of Slaughter's concept of field cancerization: evidence and clinical implications. Cancer Res. 2003, 63: 1727-1730.PubMed
38.
go back to reference Polley AC, Mulholland F, Pin C, Williams EA, Bradburn DM, Mills SJ, Mathers JC, Johnson IT: Proteomic analysis reveals field-wide changes in protein expression in the morphologically normal mucosa of patients with colorectal neoplasia. Cancer Res. 2006, 66: 6553-6562. 10.1158/0008-5472.CAN-06-0534CrossRefPubMed Polley AC, Mulholland F, Pin C, Williams EA, Bradburn DM, Mills SJ, Mathers JC, Johnson IT: Proteomic analysis reveals field-wide changes in protein expression in the morphologically normal mucosa of patients with colorectal neoplasia. Cancer Res. 2006, 66: 6553-6562. 10.1158/0008-5472.CAN-06-0534CrossRefPubMed
39.
go back to reference Corfe BM, Williams EA, Bury JP, Riley SA, Croucher LJ, Lai DY, Evans CA: A study protocol to investigate the relationship between dietary fibre intake and fermentation, colon cell turnover, global protein acetylation and early carcinogenesis: the FACT study. BMC Cancer. 2009, 9: 332- 10.1186/1471-2407-9-332PubMedCentralCrossRefPubMed Corfe BM, Williams EA, Bury JP, Riley SA, Croucher LJ, Lai DY, Evans CA: A study protocol to investigate the relationship between dietary fibre intake and fermentation, colon cell turnover, global protein acetylation and early carcinogenesis: the FACT study. BMC Cancer. 2009, 9: 332- 10.1186/1471-2407-9-332PubMedCentralCrossRefPubMed
Metadata
Title
Short-chain fatty acid level and field cancerization show opposing associations with enteroendocrine cell number and neuropilin expression in patients with colorectal adenoma
Authors
Danny CW Yu
Jonathan P Bury
James Tiernan
Jennifer S Waby
Carolyn A Staton
Bernard M Corfe
Publication date
01-12-2011
Publisher
BioMed Central
Published in
Molecular Cancer / Issue 1/2011
Electronic ISSN: 1476-4598
DOI
https://doi.org/10.1186/1476-4598-10-27

Other articles of this Issue 1/2011

Molecular Cancer 1/2011 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine